BSA nanoclusters-based sensor for detection of dopamine in schizophrenia from biofluids

Bhakti Khanolkar,Pravin Shende
DOI: https://doi.org/10.1080/03639045.2024.2328722
IF: 3.727
2024-03-22
Drug Development and Industrial Pharmacy
Abstract:Objective To develop nontoxic and stable fluorescent emission B-Cu nanoclusters (NCs) for the specific detection of dopamine at low concentrations in cerebrospinal fluid (CSF).
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?